Osmotic and non-osmotic regulation of arginine vasopressin (AVP) release, mRNA, and promoter activity in small cell lung carcinoma (SCLC) cells

Molecular and Cellular Endocrinology

Volumn 123, Issue 2, 1996, Pages 179-186

  Kim, Jin K ^a   Summer, Sandra N ^a   Wood, William M ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

AVP gene promoter; AVP mRNA; AVP release; Osmotic and non osmotic stimulation

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ARGIPRESSIN; ENDOTHELIN 3; LUCIFERASE; MESSENGER RNA;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOTHALAMUS; LUNG SMALL CELL CANCER; MAGNOCELLULAR NUCLEUS; NEUROHYPOPHYSIS; OSMOSIS; PRIORITY JOURNAL; PROMOTER REGION; RADIOIMMUNOASSAY;

ARGININE VASOPRESSIN; CARCINOMA, SMALL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OSMOLAR CONCENTRATION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030607446     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)03912-3     Document Type: Article

References (39)

1. [1] Schrrer, E. (1945) Neurosecretion. Physiol. Rev. 25, 171-181.
2. [2] DuVigneaud, V. (1956) Hormones of the posterior pituitary gland: oxytocin and vasopressin. Harvey Lect. 1954-1955, 1-26.
3. [3] Sachs, H. and Takabatake, Y. (1964) Evidence for a precursor in vasopressin biosynthesis. Endocrinology 75, 943-948.
4. [4] Brownstein, M.J., Russell, J.T. and Gainer, H. (1980) Synthesis, transport, release of posterior pituitary hormones. Science 207, 373-378.
5. [5] Robertson, G.L., Shelton, R.L. and Athar, S. (1976) The osmoregulation of vasopressin. Kidney Int. 10, 25-37.
6. [6] Schrier, R.W., Berl, T. and Anderson, R.J. (1979) Osmotic and nonosmotic control of vasopressin release. Am. J. Physiol. 236, F321-F332.
7. [7] Schrier, R.W. (1988) Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. N. Engl. J. Med. 319, 1058-1064, and 1127-1134.
8. [8] Kim, J.K., Soubrier, F., Michel, J.B., Bankir, L., Corvol, P. and Schrier, R.W. (1990) AVP gene regulation in the homozygous Brattleboro rat. J. Clin. Invest. 86, 14-16.
9. [9] Kim, J.K., Michel, J.B., Soubrier, F., Durr, J., Corvol, P. and Schrier, R.W. (1990) Arginine vasopressin gene expression in chronic cardiac failure in rats. Kidney Int. 38, 818-822.
10. [10] Kim, J.K., Summer, S.N., Howard, R.L. and Schrier, R.W. (1992) Vasopressin gene expression in rats with experimental cirrhosis. Hepatology 17, 143-147.
11. [11] Pyo, H.J., Summer, S.N., Niederberger, M., Kim, J.K. and Schrier, R.W. (1995) Arginine vasopressin gene expression in rats with puromycin-induced nephrotic syndrome. Am. J. Kidney Dis. 25, 58-62.
12. [12] Howard, R.L., Kim, J.K. and Schrier, R.W. (1995) Effect of chronic hypertonic saline ingestion on vasopressin gene expression in the rat. Am. J. Kidney Dis. 21, 535-541.
13. [13] Burbach, J.P.H., De Hoop, M.J., Schmale, H., Richter, D., De Kloet, E.R., Haaf, J.A.T. and De Wied, D. (1984) Differential responses to osmotic stress of vasopressin neurophysin mRNA in hypothalamic nuclei. Neuroendocrinology 39, 582-584.
14. [14] Zingg, H.H., Lefebvre, D.L. and Almazan, G. (1986) Regulation of vasopressin gene expression in rat hypothalamic neurons. J. Biol. Chem. 261, 12956-12959.
15. [15] Zingg, H.H., Lefebvre, D.L. and Almazan, G. (1986) Regulation of poly(A) tail size of vasopressin mRNA. J. Biol. Chem. 263, 11041-11043.
16. [16] Carrazana, E.J., Pasieka, K.B. and Majzoub, J.A. (1988) The vasopressin mRNA poly(A) tract is unusually long and increases during stimulation of vasopressin gene expression in vivo. Mol. Cell. Biol. 8, 2267-2274.
17. [17] Murphy, D. and Carter, D. (1990) Vasopressin gene expression in the rodent hypothalamus: transcriptional and posttranscriptional responses to physiological stimulation. Mol. Endocrinol. 4, 1051-1059.
18. [18] Mohr, E. and Richter, D. (1990) Sequence analysis of the promoter region of the rat vasopressin gene. FEBS Lett. 260, 305-308.
19. [19] Sausville, E., Carney, D. and Battey, J. (1986) The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J. Biol. Chem. 260, 10236-10241.
20. [20] Verbeck, M.A.E., Adan, R.A.H. and Burbach, J.P.H. (1990) Vasopressin gene expression is stimulated by cyclic AMP in homologous and heterologous expression systems. FEBS Lett. 272, 89-93.
21. [21] Verbeck, M.A.E., Sutano, W. and Burnach, J.P.H. (1991) Regulation of vasopressin messenger RNA levels in the small cell lung carcinoma cell line GLC-8: interactions between glucocorticoids and second messengers. Mol. Endocrinol. 5, 795-801.
22. [22] Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidiniumthiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
23. [23] Durnam, D.M. and Palmita, R.D. (1983) A practical approach for quantitating specific mRNAs by solution hybridization. Anal. Biochem. 131, 385-393.
24. [24] Schmale, H., Heinsohn, S. and Richter, D. (1983) Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor. EMBO J. 2, 763-767.
25. [25] Rehbein, M., Hillers, M., Mohr, E., Ivell, R., Morley, S., Schmale, H. and Richter, D. (1986) The neurohypophyseal hormones vasopressin and oxytocin, precursor structure, synthesis and regulation. Biol. Chem. Hoppe-Seyler 367, 695-704.
26. [26] Maxwell, I.H., Harrison, G.S., Wood, W.M. and Maxwell, F. (1989) A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription. BioTechniques 7, 276-280.
27. [27] Wood, W.M., Kao, M.Y., Gordon, D.F. and Ridgeway, E.C. (1989) Thyroid hormone regulates the mouse thyrotropin β subunit gene promoter in transfected primary thyrotropes. J. Biol. Chem. 264, 14840-14847.
28. [28] Potter, H., Weir, L. and Leder, P. (1984) Enhancer dependent expression of human K immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA 81, 7161-7168.
29. [29] Brasier, A.R., Tate, J.E. and Habener, J.F. (1989) Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7, 1116-1122.
30. [30] Edlund, T., Walker, M.D., Barr, P.J. and Rutter, W.J. (1985) Cell specific expression of the rat insulin gene: evidence for role of two distinct 5′ flanking elements. Science 230, 912-914.
31. [31] Rossi, N.F. (1993) Effect of endothelin-3 on vasopressin release in vitro and water excretion in vivo in Long-Evans rats. J. Physiol. 461, 510-511.
32. [32] Rossi, N.F. and Schrier, R.W. (1989) Anti-calmodulin agents affect osmotic and angiotensin II-induced vasopressin release. Am. J. Physiol. 256, E516-E523.
33. [33] Shichiri, S., Hirata, Y., Kanno, K., Ohta, K., Emori, T. and Marumo, F. (1989) Effect of endothelin-1 on release of arginine vasopressin from perifused rat hypothalamus. Biochem. Biophy. Res. Commun. 163, 1332-1337.
34. [34] Sklar, A.H. and Schrier, R.W. (1983) Central nervous system mediators of vasopressin release. Physiol. Rev. 63, 1243-1280.
35. [35] Young, W.C. (1989) Levels of transcripts encoding a member of the protein kinase C family in the paraventricular and supraoptic nuclei are increased by hyperosmolality. J. Neuroendocrinol. 1, 79-82.
36. [36] Luyken, J., Hannan, R.D., Cheug, J.Y. and Rothblum, L.I. (1996) Regulation of rDNA transcription during endothelin-1-induced hypertrophy of neonal cardiomyocytes. Hyperphosphorylation of upstream binding factor, an rDNA transcription factor. Circ. Res. 78, 354-361.
37. [37] Habener, J.F. (1990) Cyclic AMP response element binding proteins: a cornucopia of transcription factors. Mol. Endocrinol. 4, 1087-1094.
38. [38] Sethi, T., Langdon, S., Smyth, J. and Rozengurt, E. (1993) Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res. 52, 2737S-2742S.
39. [39] Murphy, D., Zeng, O. and Carter, D.A. (1993) Studies of the vasopressin promoter. The Endocrine Society, p. 28 (abstract).